...re designed for full-length gene cloning and requi... cDNA clone. The first PCR analysis is performed i...ns plasmid DNA from 5,000 clones. Having identifie...he reaction products, the second PCR analysis is c...
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
...r calibrating single-channel and multi-channel pip...st carrying case, the MCP1-S is ideal for calibrat... the users premises. The unit is extremely easy to...tomatically. Multi-channel pipettes can therefore ...
Cleland’s Reagent, Molecular Biology Grade from Calbiochem
Biology Products:(Date:11/24/2009)...swire-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),ab...rcializingnovelpainmanagementtherapies,announcedto...ficer,isscheduledtopresentatthe21stAnnualPiperJaff...TheNewYorkPalaceHotelinNewYork,NewYork. ,, Mr.D...llbeavailabletorespondtoquestionsduringthepresenta...
(Date:11/24/2009)...enmetforpatientswithadvanced-stage,orrecurrentendo...-FirstCall/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:...focusedonendocrinetherapyandoncology,todayannounce...edcytotoxicpeptideconjugate,AEZS-108(formerlyAN-15...cer.Inapersonalizedhealthcareapproach,thestudysele...
(Date:11/24/2009)...Newswire-FirstCall/--GenomicHealth,Inc.(Nasdaq: GH...ecutiveChairman,willpresentatthe21stAnnualPiperJaf...ember1,2009at10:00a.m.ET. ,, Toaccesstheliveand...theInvestorRelationssectionofGenomicHealth,swebsit...cttothewebsiteatleast15minutespriortothebeginningo...
(Date:11/24/2009)...rstCall/--CellTherapeutics,Inc.(CTI)(NasdaqandMTA:...rayHealthCareConference.TheconferencewillbeheldDec...llpresentonTuesday,December1at11:00a.m.EasternTime...tationwillbeavailableat www.celltherapeutics.com ,...iperJaffrayHealthCareConference,NewYorkPalaceHotel...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2